Price$9.02-0.11 (-1.15%)
01:45 PM07:45 PM
News · 26 weeks38-65%
2025-12-142026-06-07
Mix3190d
- Insider17(55%)
- SEC Filings10(32%)
- Other2(6%)
- Earnings2(6%)
Latest news
25 items- INSIDERExecutive VP and CFO Steele Barry G converted options into 16,226 shares, covered exercise/tax liability with 16,372 shares and was granted 21,323 shares, increasing direct ownership by 22% to 117,767 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDEREVP-Chief HR Officer Funke Jerod was granted 14,570 shares, converted options into 5,183 shares and covered exercise/tax liability with 8,761 shares, increasing direct ownership by 59% to 29,654 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERPresident and CEO Lachance Carrie converted options into 19,350 shares, covered exercise/tax liability with 12,937 shares and was granted 21,855 shares, increasing direct ownership by 12% to 266,391 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERExecutive VP and CIO Chupa Addam was granted 12,184 shares, converted options into 9,822 shares and covered exercise/tax liability with 8,056 shares, increasing direct ownership by 30% to 61,160 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem Announces $20 Million Stock Repurchase ProgramInfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company's Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company's outstanding common stock starting on July 1, 2026 and running through June 30, 2028. The program will supersede the previous authorization which is set to expire on June 30, 2026. Under the current authorization, the Company repurchased approximately 1.6 million shares of stock for approximately $11.9 million t
- SECSEC Form S-8 filed by InfuSystems Holdings Inc.S-8 - InfuSystem Holdings, Inc (0001337013) (Filer)
- INSIDERSEC Form 4 filed by Director Hundzinski Ronald T4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Director Shuda Scott4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Director Sviokla John J4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Director Huss Beverly A4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Executive VP and CIO Chupa Addam4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Director Gendron Paul Andrew4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by President and CEO Lachance Carrie4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Executive VP and CFO Steele Barry G4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by Director Eichenbaum Kenneth D.4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERSEC Form 4 filed by EVP-Chief HR Officer Funke Jerod4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- INSIDERDirector Gendron Paul Andrew bought $44,400 worth of shares (5,000 units at $8.88), increasing direct ownership by 8% to 70,000 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERPresident and CEO Lachance Carrie bought $26,120 worth of shares (3,000 units at $8.71), increasing direct ownership by 1% to 238,123 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- INSIDERExecutive VP and CFO Steele Barry G bought $60,949 worth of shares (7,000 units at $8.71), increasing direct ownership by 8% to 96,590 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- SECSEC Form 10-Q filed by InfuSystems Holdings Inc.10-Q - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem Announces Financial Results for First Quarter 2026Net Revenues of $33.7 million Representing a 3% Reduction from the Prior Year Net income of $1.0 million Adjusted EBITDA (non-GAAP) of $6.4 million Adjusted EBITDA (non-GAAP) margin expanded by 1% to 19% Reaffirms Full-Year 2026 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2026. 2026 First Quarter Overview: Net revenues totaled $33.7 million, a decrease of 3% vs. prior year. Patient Services net revenue was $22.1 million, an increa
INFU FAQ
6 questionsWhat does InfuSystems Holdings Inc. do?
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates through two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) Services. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and...Where does INFU stock trade?
InfuSystems Holdings Inc. (INFU) is listed on AMEX.What sector and industry is INFU in?
InfuSystems Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about INFU?
InfuSystems Holdings Inc. has had 3 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $1500.00 price target on 2025-09-22. Recent price targets range from $1200.00 to $1500.00.What companies are similar to INFU?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare INFU side-by-side with any of them on Quantisnow.How can I track INFU on Quantisnow?
Quantisnow aggregates InfuSystems Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow INFU to receive live email and push alerts on every new disclosure.